Best Biotech Stocks to Buy Now (2024)Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SYRS | SYROS PHARMACEUTICALS INC | $135.71M | $5.13 | $14.00 | 172.90% | Strong Buy | 2 | 160.95% | N/A | N/A | N/A | ||||
| LRMR | LARIMAR THERAPEUTICS INC | $495.41M | $7.77 | $20.00 | 157.57% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| MNOV | MEDICINOVA INC | $64.25M | $1.31 | N/A | N/A | N/A | N/A | N/A | N/A | -30.66% | -28.86% | ||||
| SLNO | SOLENO THERAPEUTICS INC | $1.46B | $45.12 | $60.75 | 34.64% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| ERAS | ERASCA INC | $324.20M | $2.14 | $7.20 | 236.45% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| VRNA | VERONA PHARMA PLC | $1.27B | $15.69 | $33.67 | 114.58% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| QNCX | QUINCE THERAPEUTICS INC | $42.57M | $0.99 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| CNTB | CONNECT BIOPHARMA HOLDINGS LTD | $87.61M | $1.59 | $8.00 | 403.14% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| VOR | VOR BIOPHARMA INC | $122.70M | $1.80 | $13.50 | 650.00% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| ABOS | ACUMEN PHARMACEUTICALS INC | $209.68M | $3.49 | $11.50 | 229.51% | Strong Buy | 2 | N/A | N/A | -27.91% | -24.02% | ||||
| THRD | THIRD HARMONIC BIO INC | $476.36M | $11.70 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| BCRX | BIOCRYST PHARMACEUTICALS INC | $917.37M | $4.45 | $11.00 | 147.19% | Strong Buy | 2 | 21.48% | N/A | N/A | N/A | ||||
| MACK | MERRIMACK PHARMACEUTICALS INC | $217.74M | $15.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| TNGX | TANGO THERAPEUTICS INC | $812.13M | $7.61 | $17.00 | 123.39% | Strong Buy | 3 | 1.25% | N/A | N/A | N/A | ||||
| RGNX | REGENXBIO INC | $747.72M | $16.83 | $40.38 | 139.90% | Strong Buy | 8 | 38.26% | N/A | N/A | N/A | ||||
| ONVO | ORGANOVO HOLDINGS INC | $10.34M | $1.03 | N/A | N/A | N/A | N/A | 47.99% | N/A | N/A | N/A | ||||
| NTRB | NUTRIBAND INC | $38.28M | $3.49 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| MTNB | MATINAS BIOPHARMA HOLDINGS INC | $38.06M | $0.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| CTMX | CYTOMX THERAPEUTICS INC | $300.01M | $4.43 | $3.13 | -29.46% | Hold | 2 | -9.84% | N/A | N/A | N/A | ||||
| AFMD | AFFIMED NV | $82.53M | $5.42 | $13.33 | 146.00% | Buy | 3 | 47.04% | N/A | N/A | N/A | ||||
| APLS | APELLIS PHARMACEUTICALS INC | $5.72B | $47.46 | $78.29 | 64.95% | Strong Buy | 14 | 58.36% | N/A | N/A | N/A | ||||
| GNLX | GENELUX CORP | $102.89M | $3.83 | $31.00 | 709.40% | Buy | 2 | 939.62% | N/A | N/A | N/A | ||||
| RCUS | ARCUS BIOSCIENCES INC | $1.43B | $15.70 | $38.60 | 145.86% | Strong Buy | 5 | 3.34% | N/A | N/A | N/A | ||||
| SCPH | SCPHARMACEUTICALS INC | $168.01M | $4.66 | $18.00 | 286.27% | Buy | 1 | 138.89% | N/A | N/A | N/A | ||||
| INMB | INMUNE BIO INC | $208.57M | $11.57 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| ORGS | ORGENESIS INC | $18.10M | $0.53 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| PRAX | PRAXIS PRECISION MEDICINES INC | $722.02M | $54.54 | $105.80 | 93.99% | Buy | 5 | 234.75% | N/A | N/A | N/A | ||||
| FTRE | FORTREA HOLDINGS INC | $3.34B | $37.41 | $38.14 | 1.96% | Buy | 7 | 3.45% | N/A | N/A | N/A | ||||
| ELAB | ELEVAI LABS INC | $12.15M | $0.70 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| PHAT | PHATHOM PHARMACEUTICALS INC | $587.11M | $10.04 | $26.00 | 158.96% | Strong Buy | 3 | 651.65% | N/A | N/A | N/A | ||||
| LEXX | LEXARIA BIOSCIENCE CORP | $40.33M | $3.13 | $12.00 | 283.39% | Strong Buy | 1 | 53.82% | N/A | N/A | N/A | ||||
| FBIO | FORTRESS BIOTECH INC | $33.66M | $1.75 | $12.50 | 614.29% | Strong Buy | 2 | 25.32% | N/A | N/A | N/A | ||||
| SYBX | SYNLOGIC INC | $21.43M | $1.84 | $15.50 | 742.39% | Buy | 2 | 86.35% | N/A | N/A | N/A | ||||
| MGX | METAGENOMI INC | $236.83M | $6.32 | $19.40 | 206.96% | Strong Buy | 5 | 6.65% | N/A | N/A | N/A | ||||
| CDXC | CHROMADEX CORP | $284.67M | $3.78 | $6.00 | 58.73% | Strong Buy | 2 | 18.04% | N/A | N/A | N/A | ||||
| OABI | OMNIAB INC | $546.98M | $4.67 | $9.00 | 92.72% | Strong Buy | 4 | 35.15% | N/A | N/A | N/A | ||||
| ADAP | ADAPTIMMUNE THERAPEUTICS PLC | $294.31M | $1.19 | N/A | N/A | N/A | N/A | 45.96% | N/A | N/A | N/A | ||||
| AUTL | AUTOLUS THERAPEUTICS PLC | $1.11B | $4.19 | $9.50 | 126.73% | Strong Buy | 2 | 368.18% | N/A | N/A | N/A | ||||
| IBRX | IMMUNITYBIO INC | $6.17B | $9.15 | $6.00 | -34.43% | Hold | 1 | 728.46% | N/A | N/A | N/A | ||||
| HRTX | HERON THERAPEUTICS INC | $392.36M | $2.61 | $5.50 | 110.73% | Buy | 2 | 17.75% | N/A | N/A | N/A | ||||
| PRQR | PROQR THERAPEUTICS NV | $163.52M | $2.01 | $3.38 | 67.91% | Buy | 4 | 18.65% | N/A | N/A | N/A | ||||
| RLMD | RELMADA THERAPEUTICS INC | $111.04M | $3.68 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| MURA | MURAL ONCOLOGY PLC | $64.81M | $3.83 | $13.00 | 239.43% | Strong Buy | 1 | N/A | N/A | N/A | N/A | ||||
| ADTX | ADITXT INC | $3.83M | $2.30 | N/A | N/A | N/A | N/A | 25.00% | N/A | N/A | N/A | ||||
| HEPA | HEPION PHARMACEUTICALS INC | $7.99M | $1.46 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| OLMA | OLEMA PHARMACEUTICALS INC | $596.61M | $10.67 | $22.50 | 110.87% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| IVVD | INVIVYD INC | $288.52M | $2.42 | $9.50 | 292.56% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| ATXI | AVENUE THERAPEUTICS INC | $2.82M | $4.78 | $56.25 | 1,076.78% | Strong Buy | 1 | N/A | N/A | N/A | N/A | ||||
| GOVX | GEOVAX LABS INC | $3.50M | $1.61 | $120.00 | 7,353.42% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| LXEO | LEXEO THERAPEUTICS INC | $340.56M | $12.77 | $21.20 | 66.01% | Strong Buy | 5 | N/A | N/A | N/A | N/A | ||||
| GLTO | GALECTO INC | $18.98M | $0.70 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| CARM | CARISMA THERAPEUTICS INC | $67.30M | $1.62 | $7.50 | 362.96% | Strong Buy | 2 | 57.65% | N/A | N/A | N/A | ||||
| SGMT | SAGIMET BIOSCIENCES INC | $137.87M | $4.32 | $32.75 | 658.10% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| SLRN | ACELYRIN INC | $427.89M | $4.35 | $14.80 | 240.23% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| MIRA | MIRA PHARMACEUTICALS INC | $10.83M | $0.73 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| SRZN | SURROZEN INC | $31.99M | $10.00 | N/A | N/A | N/A | N/A | N/A | N/A | -160.63% | -132.23% | ||||
| THTX | THERATECHNOLOGIES INC | $58.85M | $1.28 | N/A | N/A | N/A | N/A | 19.17% | N/A | N/A | N/A | ||||
| IMRX | IMMUNEERING CORP | $48.02M | $1.64 | $13.40 | 717.07% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| RNAC | CARTESIAN THERAPEUTICS INC | $138.20M | $25.60 | $47.00 | 83.59% | Buy | 3 | 36.39% | N/A | N/A | N/A | ||||
| INZY | INOZYME PHARMA INC | $292.80M | $4.74 | $17.00 | 258.65% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $770.34M | $15.36 | $18.25 | 18.82% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| EWTX | EDGEWISE THERAPEUTICS INC | $1.82B | $19.52 | $32.75 | 67.78% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $265.46M | $1.89 | $5.00 | 164.55% | Strong Buy | 3 | 16.29% | N/A | N/A | N/A | ||||
| IRON | DISC MEDICINE INC | $735.25M | $29.79 | $69.60 | 133.64% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| IMVT | IMMUNOVANT INC | $4.19B | $28.86 | $51.33 | 77.87% | Strong Buy | 9 | N/A | N/A | N/A | N/A | ||||
| FBRX | FORTE BIOSCIENCES INC | $25.99M | $0.71 | $2.75 | 285.15% | Strong Buy | 1 | N/A | N/A | N/A | N/A | ||||
| ONCT | ONCTERNAL THERAPEUTICS INC | $25.88M | $8.75 | $34.00 | 288.79% | Strong Buy | 2 | -3.06% | N/A | N/A | N/A | ||||
| TSBX | TURNSTONE BIOLOGICS CORP | $62.83M | $2.72 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| DRTS | ALPHA TAU MEDICAL LTD | $173.48M | $2.49 | $8.00 | 221.29% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| APVO | APTEVO THERAPEUTICS INC | $527.60k | $0.99 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| RCKT | ROCKET PHARMACEUTICALS INC | $2.12B | $23.47 | $54.33 | 131.50% | Strong Buy | 6 | N/A | N/A | N/A | N/A | ||||
| VIGL | VIGIL NEUROSCIENCE INC | $111.76M | $3.03 | $18.50 | 510.56% | Hold | 4 | N/A | N/A | N/A | N/A | ||||
| NNVC | NANOVIRICIDES INC | $13.31M | $1.13 | $6.50 | 475.22% | Strong Buy | 1 | N/A | N/A | N/A | N/A | ||||
| RAPT | RAPT THERAPEUTICS INC | $289.86M | $8.33 | $21.00 | 152.10% | Buy | 6 | N/A | N/A | N/A | N/A | ||||
| VRPX | VIRPAX PHARMACEUTICALS INC | $2.62M | $2.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| REPL | REPLIMUNE GROUP INC | $426.65M | $6.95 | $37.67 | 441.97% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| TRML | TOURMALINE BIO INC | $406.24M | $15.84 | $64.67 | 308.25% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| LBPH | LONGBOARD PHARMACEUTICALS INC | $831.06M | $21.38 | $43.67 | 104.29% | Strong Buy | 6 | N/A | N/A | N/A | N/A | ||||
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $2.89B | $45.26 | $77.00 | 70.13% | Strong Buy | 8 | N/A | N/A | N/A | N/A | ||||
| COGT | COGENT BIOSCIENCES INC | $782.47M | $7.53 | $13.67 | 81.50% | Buy | 6 | N/A | N/A | N/A | N/A | ||||
| RZLT | REZOLUTE INC | $131.16M | $3.31 | $9.75 | 194.56% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| CRVS | CORVUS PHARMACEUTICALS INC | $94.15M | $1.92 | $5.25 | 173.44% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| ZURA | ZURA BIO LTD | $201.40M | $4.62 | $21.00 | 354.55% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| ATHE | ALTERITY THERAPEUTICS LTD | $11.49M | $2.05 | $4.00 | 95.12% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| SRRK | SCHOLAR ROCK HOLDING CORP | $1.20B | $15.35 | $27.00 | 75.90% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| CRGX | CARGO THERAPEUTICS INC | $800.25M | $20.33 | $29.67 | 45.93% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| SNTI | SENTI BIOSCIENCES INC | $16.93M | $0.37 | N/A | N/A | N/A | N/A | 48.38% | N/A | N/A | N/A | ||||
| ADCT | ADC THERAPEUTICS SA | $404.39M | $4.90 | $9.33 | 90.47% | Strong Buy | 3 | 27.34% | N/A | N/A | N/A | ||||
| ELDN | ELEDON PHARMACEUTICALS INC | $59.80M | $2.41 | $13.00 | 439.42% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| ACHL | ACHILLES THERAPEUTICS PLC | $33.03M | $0.80 | $2.83 | 252.36% | Hold | 3 | N/A | N/A | N/A | N/A | ||||
| GOSS | GOSSAMER BIO INC | $166.93M | $0.74 | $8.60 | 1,062.16% | Strong Buy | 5 | N/A | N/A | N/A | N/A | ||||
| INTS | INTENSITY THERAPEUTICS INC | $52.92M | $3.86 | $12.00 | 210.88% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| ALVR | ALLOVIR INC | $91.67M | $0.80 | $1.17 | 46.24% | Hold | 3 | N/A | N/A | N/A | N/A | ||||
| NMRA | NEUMORA THERAPEUTICS INC | $1.47B | $9.25 | $26.50 | 186.49% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| COYA | COYA THERAPEUTICS INC | $126.23M | $8.68 | $14.00 | 61.29% | Strong Buy | 1 | N/A | N/A | N/A | N/A | ||||
| TCBP | TC BIOPHARM (HOLDINGS) PLC | $4.66M | $1.46 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| TCON | TRACON PHARMACEUTICALS INC | $4.23M | $1.86 | $60.00 | 3,125.81% | Buy | 1 | 50.59% | N/A | N/A | N/A | ||||
| ENTA | ENANTA PHARMACEUTICALS INC | $320.94M | $15.17 | $20.75 | 36.78% | Hold | 4 | 1.61% | N/A | N/A | N/A | ||||
| ACRV | ACRIVON THERAPEUTICS INC | $217.09M | $9.59 | $21.20 | 121.06% | Strong Buy | 5 | N/A | N/A | N/A | N/A | ||||
| TENX | TENAX THERAPEUTICS INC | $7.52M | $3.84 | $30.00 | 681.25% | Strong Buy | 1 | N/A | N/A | N/A | N/A |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.